Ali Behbahani - May 16, 2023 Form 4 Insider Report for Black Diamond Therapeutics, Inc. (BDTX)

Role
Director
Signature
/s/ Louis Citron, attorney-in-fact
Stock symbol
BDTX
Transactions as of
May 16, 2023
Transactions value $
$0
Form type
4
Date filed
5/17/2023, 09:16 PM
Previous filing
Mar 20, 2023
Next filing
Jun 5, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDTX Stock Option (right to buy) Award $0 +16.5K $0.00 16.5K May 16, 2023 Common Stock 16.5K $1.82 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) May 16, 2024 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date.